These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3270915)

  • 1. [Dysfibrinogenemia and dysprothrombinemia].
    Miyata T; Iwanaga S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):959-63. PubMed ID: 3270915
    [No Abstract]   [Full Text] [Related]  

  • 2. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia.
    Sun WY; Burkart MC; Holahan JR; Degen SJ
    Blood; 2000 Jan; 95(2):711-4. PubMed ID: 10627484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inherited dysfibrinogenemia caused by Arg275His in the beta chain of fibrinogen].
    Fang Y; Wang X; Qi H; Wu W; Ding Q; Dai J; Zhou R; Wang W; Xie S; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):201-3. PubMed ID: 15793786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen recovery in fibrinolytic dogs. Influence of vitamin K.
    Dulock MA; Kolmen SN
    Thromb Diath Haemorrh; 1970 Feb; 23(1):58-63. PubMed ID: 4192652
    [No Abstract]   [Full Text] [Related]  

  • 5. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin.
    Rouy S; Vidaud D; Alessandri JL; Dautzenberg MD; Venisse L; Guillin MC; Bezeaud A
    Br J Haematol; 2006 Mar; 132(6):770-3. PubMed ID: 16487178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different sensitivity of von Clauss reagents for the diagnosis of dysfibrinogenemia.
    Vasse M; Francois D; Van Dreden P; de Mazancourt P
    Eur J Haematol; 2020 Jan; 104(1):70-71. PubMed ID: 31583746
    [No Abstract]   [Full Text] [Related]  

  • 7. A new variant of human prothrombin: prothrombin Metz, demonstration in a family showing double heterozygosity for congenital hypoprothrombinemia and dysprothrombinemia.
    Josso F; Rio Y; Béguin S
    Haemostasis; 1982; 12(4):309-16. PubMed ID: 7152370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin Suresnes: a case of homozygous F299V mutation responsible for hypodysprothrombinemia.
    François D; Chevreaud C; Vignon D; de Mazancourt P
    Haematologica; 2006 Mar; 91(3):431-2. PubMed ID: 16503555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular-biology findings on various blood clotting factors].
    Fiedler H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
    Meeks SL; Abshire TC
    Haemophilia; 2008 Nov; 14(6):1159-63. PubMed ID: 19141155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution.
    Korte W; Feldges A
    Clin Investig; 1994 May; 72(5):396-8. PubMed ID: 8086775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
    O'Marcaigh AS; Nichols WL; Hassinger NL; Mullins JD; Mallouh AA; Gilchrist GS; Owen WG
    Blood; 1996 Oct; 88(7):2611-8. PubMed ID: 8839854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
    Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
    Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
    Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
    Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare inherited disorders of fibrinogen.
    Acharya SS; Dimichele DM
    Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofibrinogenaemia associated with common gamma82Ala-->Gly mutation is not mediated by altered mRNA splicing.
    Brennan SO; Homer VM; Davis RL; Meyer M; George PM
    Thromb Haemost; 2006 Oct; 96(4):535-7. PubMed ID: 17003934
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion.
    Wong AY; Hewitt J; Clarke BJ; Hudson DM; Krisinger MJ; Dower NA; MacGillivray RT
    J Thromb Haemost; 2006 Dec; 4(12):2623-8. PubMed ID: 17002658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital molecular anomalies of fibrinogen and prothrombin].
    Rocha E; Fernández Díaz FJ; Cuesta B; Páramo JA; Rifón J
    Sangre (Barc); 1989 Jun; 34(3):210-20. PubMed ID: 2669185
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.